Patents by Inventor Tomomi Ueno

Tomomi Ueno has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230270142
    Abstract: An object of the invention is to provide an equol-containing fermented soybean hypocotyl material that is useful for foods, pharmaceutical preparations, cosmetic products, etc. The equol-containing fermented soybean hypocotyl material of the invention is obtained by fermenting soybean hypocotyls using at least one microorganism having an equol-producing ability by utilizing at least one daidzein compound selected from the group consisting of diadzein glycosides, daidzein, and dihydrodaidzein.
    Type: Application
    Filed: September 29, 2022
    Publication date: August 31, 2023
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Hiroyuki KIMURA, Takeshi YAMAUCHI, Tomomi UENO, Toshimi SUZUKI, Kentaro TADANO, Ikutaro SATO, Shigeto UCHIYAMA, Masahiro OONO, Masatoshi MIZUNO
  • Publication number: 20210361616
    Abstract: An ameliorating agent for a female-specific physical and/or mental unpleasant symptom, which contains ?-tocopherol and/or equol. A method of ameliorating a female-specific physical and/or mental unpleasant symptom, the method including administering ?-tocopherol and equol, wherein 0.1 to 1000 mg per day of ?-tocopherol and 0.1 to 50 mg per day of equol are administered.
    Type: Application
    Filed: August 9, 2021
    Publication date: November 25, 2021
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Tomomi UENO, Tomoko Deguchi, Atsuko Onoda
  • Publication number: 20210361615
    Abstract: An ameliorating agent for a female-specific physical and/or mental unpleasant symptom, which contains ?-tocopherol and/or equol. A method of ameliorating a female-specific physical and/or mental unpleasant symptom, the method including administering ?-tocopherol and equol, wherein 0.1 to 1000 mg per day of ?-tocopherol and 0.1 to 50 mg per day of equol are administered.
    Type: Application
    Filed: August 9, 2021
    Publication date: November 25, 2021
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Tomomi UENO, Tomoko DEGUCHI, Atsuko ONODA
  • Publication number: 20190099399
    Abstract: The present invention provides an ameliorating agent for a female-specific physical and/or mental unpleasant symptom, which comprises ?-tocopherol and/or equol.
    Type: Application
    Filed: March 7, 2017
    Publication date: April 4, 2019
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Tomomi UENO, Tomoko DEGUCHI, Atsuko ONODA
  • Publication number: 20190038684
    Abstract: An equol-producing lactic acid bacteria-containing composition comprises, as an essential component thereof, a lactic acid bacterial strain belonging to the genus Lactococcus having an ability to utilize at least one daidzein compound selected from the group consisting of daidzein glycosides, daidzein, and dihydrodaidzein to produce equol. Such a composition is effective for the prevention and alleviation of malaise inclusive of climacteric disturbance in middle-aged and elderly women for which no effective prophylactic method or alleviating means has heretofore been available.
    Type: Application
    Filed: October 12, 2018
    Publication date: February 7, 2019
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Shigeto UCHIYAMA, Tomomi UENO, Toshimi SUZUKI
  • Patent number: 10098915
    Abstract: An equol-producing lactic acid bacteria-containing composition comprises, as an essential component thereof, a lactic acid bacterial strain belonging to the genus Lactococcus having an ability to utilize at least one daidzein compound selected from the group consisting of daidzein glycosides, daidzein, and dihydrodaidzein to produce equol. Such a composition is effective for the prevention and alleviation of malaise inclusive of climacteric disturbance in middle-aged and elderly women for which no effective prophylactic method or alleviating means has heretofore been available.
    Type: Grant
    Filed: September 24, 2013
    Date of Patent: October 16, 2018
    Assignee: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Shigeto Uchiyama, Tomomi Ueno, Toshimi Suzuki
  • Publication number: 20180235260
    Abstract: An object of the invention is to provide an equol-containing fermented soybean hypocotyl material that is useful for foods, pharmaceutical preparations, cosmetic products, etc. The equol-containing fermented soybean hypocotyl material of the invention is obtained by fermenting soybean hypocotyls using at least one microorganism having an equol-producing ability by utilizing at least one daidzein compound selected from the group consisting of diadzein glycosides, daidzein, and dihydrodaidzein.
    Type: Application
    Filed: April 18, 2018
    Publication date: August 23, 2018
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Hiroyuki KIMURA, Takeshi YAMAUCHI, Tomomi UENO, Toshimi SUZUKI, Kentaro TADANO, Ikutaro SATO, Shigeto UCHIYAMA, Masahiro OONO, Masatoshi MIZUNO
  • Patent number: 9951360
    Abstract: An object of the present invention is to provide a fermented product containing equol-producing microorganisms in the state of living cells by which equol production ability is maintained. When producing a fermented material by using an equol-producing microorganism, with soybean powder or soybean milk as raw materials, (1) preparing a mother starter by fermentation under anaerobic conditions by using an equol-producing microorganism in the presence of a daidzein species at pH 5.0 or higher, (2) preparing a bulk starter by fermentation under anaerobic conditions by using said mother starter in the presence of a daidzein species at pH 5.0 or higher, and (3) preparing a fermented material by fermentation by using said bulk starter in a medium containing soybean powder or soybean milk, enables production of a fermented material containing microorganisms in the state of living cells in which the equol production ability is maintained.
    Type: Grant
    Filed: June 30, 2015
    Date of Patent: April 24, 2018
    Assignee: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Yoshikazu Isono, Hisako Mori, Tomomi Ueno, Rieko Endo, Megumi Kumemura, Yasuhiro Abiru, Shigeto Uchiyama
  • Patent number: 9386786
    Abstract: An object of the invention is to provide an equol-containing fermented soybean hypocotyl material that is useful for foods, pharmaceutical preparations, cosmetic products, etc. The equol-containing fermented soybean hypocotyl material of the invention is obtained by fermenting soybean hypocotyls using at least one microorganism having an equol-producing ability by utilizing at least one daidzein compound selected from the group consisting of diadzein glycosides, daidzein, and dihydrodaidzein.
    Type: Grant
    Filed: July 16, 2012
    Date of Patent: July 12, 2016
    Assignee: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Hiroyuki Kimura, Takeshi Yamauchi, Tomomi Ueno, Toshimi Suzuki, Kentaro Tadano, Ikutaro Sato, Shigeto Uchiyama, Masahiro Oono, Masatoshi Mizuno
  • Publication number: 20150299748
    Abstract: An object of the present invention is to provide a fermented product containing equol-producing microorganisms in the state of living cells by which equol production ability is maintained. When producing a fermented material by using an equol-producing microorganism, with soybean powder or soybean milk as raw materials, (1) preparing a mother starter by fermentation under anaerobic conditions by using an equol-producing microorganism in the presence of a daidzein species at pH 5.0 or higher, (2) preparing a bulk starter by fermentation under anaerobic conditions by using said mother starter in the presence of a daidzein species at pH 5.0 or higher, and (3) preparing a fermented material by fermentation by using said bulk starter in a medium containing soybean powder or soybean milk, enables production of a fermented material containing microorganisms in the state of living cells in which the equol production ability is maintained.
    Type: Application
    Filed: June 30, 2015
    Publication date: October 22, 2015
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Yoshikazu ISONO, Hisako MORI, Tomomi UENO, Rieko ENDO, Megumi KUMEMURA, Yasuhiro ABIRU, Shigeto UCHIYAMA
  • Patent number: 9101159
    Abstract: An object of the present invention is to provide a fermented product containing equol-producing microorganisms in the state of living cells by which equol production ability is maintained. When producing a fermented material by using an equol-producing microorganism, with soybean powder or soybean milk as raw materials, (1) preparing a mother starter by fermentation under anaerobic conditions by using an equol-producing microorganism in the presence of a daidzein species at pH 5.0 or higher, (2) preparing a bulk starter by fermentation under anaerobic conditions by using said mother starter in the presence of a daidzein species at pH 5.0 or higher, and (3) preparing a fermented material by fermentation by using said bulk starter in a medium containing soybean powder or soybean milk, enables production of a fermented material containing microorganisms in the state of living cells in which the equol production ability is maintained.
    Type: Grant
    Filed: September 18, 2009
    Date of Patent: August 11, 2015
    Assignee: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Yoshikazu Isono, Hisako Mori, Tomomi Ueno, Rieko Endo, Megumi Kumemura, Yasuhiro Abiru, Shigeto Uchiyama
  • Patent number: 8765445
    Abstract: The present invention provides an equol-producing lactic acid bacteria-containing composition comprising, as an essential component thereof, a lactic acid bacterial strain belonging to the genus Lactococcus having an ability to utilize at least one daidzein compound selected from the group consisting of daidzein glycosides, daidzein, and dihydrodaidzein to produce equol. Such a composition is effective for the prevention and alleviation of malaise inclusive of climacteric disturbance in middle-aged and elderly women for which no effective prophylactic method or alleviating means has heretofore been available.
    Type: Grant
    Filed: June 29, 2004
    Date of Patent: July 1, 2014
    Assignee: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Shigeto Uchiyama, Tomomi Ueno, Toshimi Suzuki
  • Publication number: 20140050703
    Abstract: An equol-producing lactic acid bacteria-containing composition comprises, as an essential component thereof, a lactic acid bacterial strain belonging to the genus Lactococcus having an ability to utilize at least one daidzein compound selected from the group consisting of daidzein glycosides, daidzein, and dihydrodaidzein to produce equol. Such a composition is effective for the prevention and alleviation of malaise inclusive of climacteric disturbance in middle-aged and elderly women for which no effective prophylactic method or alleviating means has heretofore been available.
    Type: Application
    Filed: September 24, 2013
    Publication date: February 20, 2014
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Shigeto UCHIYAMA, Tomomi UENO, Toshimi SUZUKI
  • Publication number: 20120277302
    Abstract: An object of the invention is to provide an equol-containing fermented soybean hypocotyl material that is useful for foods, pharmaceutical preparations, cosmetic products, etc. The equol-containing fermented soybean hypocotyl material of the invention is obtained by fermenting soybean hypocotyls using at least one microorganism having an equol-producing ability by utilizing at least one daidzein compound selected from the group consisting of diadzein glycosides, daidzein, and dihydrodaidzein.
    Type: Application
    Filed: July 16, 2012
    Publication date: November 1, 2012
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Hiroyuki Kimura, Takeshi Yamauchi, Tomomi Ueno, Toshimi Suzuki, Kentaro Tadano, Ikutaro Sato, Shigeto Uchiyama, Masahiro Oono, Masatoshi Mizuno
  • Publication number: 20120277303
    Abstract: An object of the invention is to provide an equol-containing fermented soybean hypocotyl material that is useful for foods, pharmaceutical preparations, cosmetic products, etc. The equol-containing fermented soybean hypocotyl material of the invention is obtained by fermenting soybean hypocotyls using at least one microorganism having an equol-producing ability by utilizing at least one daidzein compound selected from the group consisting of diadzein glycosides, daidzein, and dihydrodaidzein.
    Type: Application
    Filed: July 16, 2012
    Publication date: November 1, 2012
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD
    Inventors: Hiroyuki KIMURA, Takeshi YAMAUCHI, Tomomi UENO, Toshimi SUZUKI, Kentaro TADANO, Ikutaro SATO, Shigeto UCHIYAMA, Masahiro OONO, Masatoshi MIZUNO
  • Publication number: 20110189134
    Abstract: An object of the present invention is to provide a fermented product containing equol-producing microorganisms in the state of living cells by which equol production ability is maintained. When producing a fermented material by using an equol-producing microorganism, with soybean powder or soybean milk as raw materials, (1) preparing a mother starter by fermentation under anaerobic conditions by using an equol-producing microorganism in the presence of a daidzein species at pH 5.0 or higher, (2) preparing a bulk starter by fermentation under anaerobic conditions by using said mother starter in the presence of a daidzein species at pH 5.0 or higher, and (3) preparing a fermented material by fermentation by using said bulk starter in a medium containing soybean powder or soybean milk, enables production of a fermented material containing microorganisms in the state of living cells in which the equol production ability is maintained.
    Type: Application
    Filed: September 18, 2009
    Publication date: August 4, 2011
    Applicants: OTSUKA PHARMACEUTICAL CO., LTD., OTSUKA FOODS CO., LTD.
    Inventors: Yoshikazu Isono, Hisako Mori, Tomomi Ueno, Rieko Endo, Megumi Kumemura, Yasuhiro Abiru, Shigeto Uchiyama
  • Patent number: 7939060
    Abstract: This invention provides a composition comprising a daidzein-containing substrate and a strain of micro-organism capable of metabolizing daidzein to equol as essential ingredients. This composition is effective in the prevention and alleviation of unidentified clinical syndrome inclusive of menopausal syndrome in middle-aged to elderly women for which no effective means of prevention or alleviation has heretofore been available.
    Type: Grant
    Filed: January 9, 2008
    Date of Patent: May 10, 2011
    Assignee: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Shigeto Uchiyama, Tomomi Ueno, Megumi Kumemura, Kiyoko Imaizumi, Kyosuke Masaki, Seiichi Shimizu
  • Publication number: 20090311353
    Abstract: An object of the invention is to provide an equol-containing fermented soybean hypocotyl material that is useful for foods, pharmaceutical preparations, cosmetic products, etc. The equol-containing fermented soybean hypocotyl material of the invention is obtained by fermenting soybean hypocotyls using at least one microorganism having an equol-producing ability by utilizing at least one daidzein compound selected from the group consisting of diadzein glycosides, daidzein, and dihydrodaidzein.
    Type: Application
    Filed: December 5, 2006
    Publication date: December 17, 2009
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD
    Inventors: Hiroyuki Kimura, Takeshi Yamauchi, Tomomi Ueno, Toshimi Suzuki, Kentaro Tadano, Ikutaro Sato, Shigeto Uchiyama, Masahiro Oono, Masatoshi Mizuno
  • Publication number: 20080131412
    Abstract: This invention provides a composition comprising a daidzein-containing substrate and a strain of micro-organism capable of metabolizing daidzein to equol as essential ingredients. This composition is effective in the prevention and alleviation of unidentified clinical syndrome inclusive of menopausal syndrome in middle-aged to elderly women for which no effective means of prevention or alleviation has heretofore been available.
    Type: Application
    Filed: January 9, 2008
    Publication date: June 5, 2008
    Inventors: Shigeto Uchiyama, Tomomi Ueno, Megumi Kumemura, Kiyoko Imaizumi, Kyosuke Masaki, Seiichi Shimizu
  • Patent number: 7345089
    Abstract: This invention provides a composition comprising a daidzein-containing substrate and a strain of micro-organism capable of metabolizing daidzein to equol as essential ingredients. This composition is effective in the prevention and alleviation of unidentified clinical syndrome inclusive of menopausal syndrome in middle-aged to elderly women for which no effective means of prevention or alleviation has heretofore been available.
    Type: Grant
    Filed: January 8, 2004
    Date of Patent: March 18, 2008
    Assignee: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Shigeto Uchiyama, Tomomi Ueno, Megumi Kumemura, Kiyoko Imaizumi, Kyosuke Masaki, Seiichi Shimizu